期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

特发性肺纤维化与肺动脉高压 被引量：1

下载PDF
导出
摘要 特发性肺纤维化（idiopathic pulmonary fibrosis,IPF）是指原因不明并以普通型间质性肺炎（usual interstitial pneumonia,UIP）为特征性病理改变的一种慢性炎症性间质性疾病，主要表现为弥漫性肺泡炎、肺泡单位结构紊乱和肺纤维化。病情多呈进行性发展，晚期可出现发绀、肺动脉高压（pulmonary arterial hypertension, PAH）、肺源性心脏病、右心功能不全等。
作者 李惠萍
机构地区 同济大学附属上海市肺科医院呼吸科
出处 《内科理论与实践》 2008年第6期382-386,共5页 Journal of Internal Medicine Concepts & Practice
关键词 特发性肺纤维化 肺动脉高压 发病机制
分类号 R563.9 [医药卫生—呼吸系统] R543.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献13

  • 1谢万木,翟振国,童朝辉,王辰.肺动脉高压治疗进展[J].中国实用内科杂志,2007,27(6):479-482. 被引量：2
  • 2杨媛华,王辰.肺动脉高压的发病机制及治疗进展[J].国外医学（呼吸系统分册）,2004,24(5):323-325. 被引量：12
  • 3李惠萍,何国钧.间质性肺疾病胶原合成与降解的研究新进展[J].国外医学（呼吸系统分册）,2002,22(2):82-84. 被引量：5
  • 4Fell CD,Martinez FJ.The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis[].Chest.2007
  • 5Nadrous HF,Pellikka PA,Krowka MJ,et al.The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis[].Chest.2005
  • 6Nathan SD,Shlobin OA,Ahmad S,et al.Pulmonary hy-pertension and pulmonary function testing in idiopathic pulmonary fibrosis[].Chest.2007
  • 7Nathan SD,Noble PW,Tuder RM.Idiopathic pulmonary fibrosis and pulmonary hypertension[].American Journal of Respiratory and Critical Care Medicine.2007
  • 8Handa T,Nagai S,Miki S,et al.Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias:comparison between idiopathic and collagen vascular disease associated interstitial pneu-monias[].Journal of Internal Medicine.2007
  • 9Patel NM,Lederer DJ,Borczuk AC,et al.Pulmonary hypertension in idiopathic pulmonary fibrosis[].Chest.2007
  • 10Colombat M,Mal H,Groussard O,et al.Pulmonary vas-cular lesions in end-stage idiopathic pulmonary fibrosis:histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics[].Human Pathology.2007

二级参考文献47

  • 1Janssen B,Rindermann M,Barth U,et al.Linkage analysis in a large family with PPH:genetic heterogeneity and a second PPH Locus on 2 q31-32.Chest,2002,121(Suppl):54S-56S.
  • 2Christman BW,McPherson CD,Newman JH,et al.An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.N Engl J Med,1992,327:70-75.
  • 3Hoshikawa Y,Voelkel NF,Gesell TL,et al.Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling.Am J Respir Crit Care Med,2001,164:314-318.
  • 4Tuder RM,Cool CD,Geraci MW,et al.Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.Am J Respir Crit Care Med,1999,159:1925-1932.
  • 5Voelkel NF,Tuder RM,Wade K,et al.Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.J Clin Invest,1996,97:2491-2498.
  • 6Massague J,Blain SW,Lo RS.TGF- signalling in growth control,cancer,and heritable disorders.Cell,2000,103:295-309.
  • 7Gaine SP,Rubin LJ.Primary pulmonary hypertension.Lancet,1998,352:719-725.
  • 8Wright L,Tuder RM,Wang J,et al.5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.Am J Respir Crit Care Med,1998,157:219-229.
  • 9Simmoneau G,Barst R,Galie N,et al.Continuous subcutaneous infusion of treprostinil,a prostacyclin analogue,in patients with pulmonary arterial hypertension.Am J Respit Crit Care Med,2002,165:800-804.
  • 10Fruhwald FM,Kjellstrom B,Perthold W,et al.Continuous hemodynamic monitoring in pulmonary hypertensive patients treated with inhaled iloprost.Chest,2003,124:351-359.

共引文献16

同被引文献29

  • 1王浩凌,谢敏.肝细胞生长因子与特发性肺纤维化[J].国际呼吸杂志,2007,27(8):602-604. 被引量：3
  • 2McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on ExpertConsensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians ; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association [ J ] . J Am Coll Cardiol. 2009. 53 ( 17 ) : 1573-1619.
  • 3Nakamura Y, Morishita R, I-Iigaki J, et al. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors : additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor [ J ] . J Hypertens, 1996, 14 (9) : 1067-1072.
  • 4Ware LB, Matthay MA. Keratinoeyte and hepatoeyte growth factors in the lung : roles in lung development, inflammation, and repair [ J ] . Am J Physiol Lung Cell Mol Physiol, 2002, 282 ( 5 ) : L924-L940.
  • 5Abid MR, Nadeau R J, Spokes KC, et al. Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells [ J ] . Arterioscler Thromb Vase Biol, 2008, 28 ( 11 ) : 2042- 2048.
  • 6Padela S, Cabaeungan J, Shek S, et al. Hepatoeyte growth factor is required for alveologenesis in the neonatal rat[J].Am J Respir Crit Care Med, 2005, 172 ( 7 ) : 907-914.
  • 7Togo S, Sugiura H, Nelson A, et al. Hepatic growth factor ( HGF ) inhibits cigarette smoke extract induced apoptosis in human bronchial epithelial cells [ J ] . Exp Cell Res, 2010, 316 ( 20 ) : 3501-3511.
  • 8Myerburg MM, Latoehe JD, McKenna EE, et al. Hepatoeyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells [ J ] . Am J Physiol Lung Cell Mol Physiol, 2007, 292 (6): L1352-L1360.
  • 9Zhu G, Huang L, Song M, et al. Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation [ J ] . Int J Cardiol, 2010, 138 ( 1 ) : 70-80.
  • 10Duan HF, Wu CT, Lu Y, et al. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial ceils [ J ] . Exp Cell Res, 2004, 298 ( 2 ) : 593-601.

引证文献1

内科理论与实践
2008年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部